hello

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.

hello

Hello! How can I help you today?

Hi. I am medical student. Resident, second year medicine. Um...

Hi, good to meet you. What's on your mind - a case you're working through, a topic you want to review, or something you're prepping for (exam, rounds, presentation)? Go ahead and share the details whenever you're ready.

Uh, 70-year-old male came to the hospital. With complaint of one episode of syncope at home and, uh, no known com- comorbid, but he has chest pain and breathlessness since one week. On admission, ECG was done which show complete LBB, ST elevation in lead V2 to V6. Drop is raised. Other investigations are normal. 2D echo was done, which show ischemic heart disease, RWM in LAD, uh, severe aortic wall degeneration, severe AS. Please. Give me the order sheet of this patient, other investigations, complications, adverse effect, what to monitor daily, de- differential diagnosis.

Reading File

Finding Sources

Searching PubMed

"aortic stenosis" AND "myocardial infarction" AND management

Quick answer

Clinical Summary

70-year-old male, no known comorbidities, presenting with:

Syncope (1 episode, at home)
Chest pain and breathlessness x 1 week
ECG: New/presumed-new complete LBBB with ST elevation V2-V6
Elevated troponin
2D Echo: Ischemic heart disease with RWMA in LAD territory, severe degenerative aortic valve disease with severe AS

Working diagnosis: Anterior wall STEMI (LAD territory) with new-onset complete LBBB, superimposed on pre-existing severe calcific/degenerative aortic stenosis. Syncope here is most likely arrhythmic/ischemic (transient complete heart block or ventricular arrhythmia from acute MI) rather than classic exertional AS-syncope, though severe AS itself is an independent cause of syncope. New LBBB + ST elevation + raised troponin meets STEMI-equivalent criteria (Sgarbossa-type reasoning) - this needs to be treated as a STEMI activation.

This is a genuinely high-risk combination: acute MI + new LBBB (risk of complete heart block) + severe AS (limits preload/afterload reserve, complicates PCI hemodynamics, and standard STEMI drugs like nitrates/high-dose beta blockers can be dangerous in severe AS).

1. Differential Diagnosis

For the syncope + chest pain + new LBBB + ST elevation presentation:

Acute anterior STEMI (LAD occlusion) with new LBBB - most likely, given RWMA on echo
Transient paroxysmal complete heart block from acute ischemia/LBBB progressing to AV block - explains syncope
Syncope due to critical AS itself (exertional/effort syncope from fixed outflow obstruction) - independent contributor
Malignant ventricular arrhythmia (VT/VF) secondary to acute ischemia, self-terminated - possible cause of syncope
Type 2 MI from severe AS causing supply-demand mismatch (severe LVH, low coronary flow reserve) rather than primary plaque rupture
Acute aortic dissection (must be excluded before anticoagulation/thrombolysis given syncope + chest pain, especially if any pulse/BP differential, though ST elevation with RWMA makes this less likely)
Stress (Takotsubo) cardiomyopathy - less likely given LBBB and matching RWMA to LAD territory, but consider if angiography is clean

2. Admission Order Sheet

Diagnosis: Acute Anterior STEMI (LAD territory) with new-onset complete LBBB; Severe degenerative Aortic Stenosis; Syncope, likely cardiogenic

Admit to: Coronary Care Unit / ICU, continuous cardiac monitoring, on strict bed rest

Vitals: Continuous ECG monitoring, HR/BP/SpO2 q1h for first 6-12h then q2-4h; strict input/output charting

Nursing care:

Nil per oral until hemodynamic/rhythm stability confirmed and PCI plan decided
Oxygen only if SpO2 <90%
IV access x2, keep NPO if cath lab planned
Temporary pacemaker stand-by (transcutaneous pads on patient) - given new LBBB with risk of progression to complete heart block
Strict avoidance of nitrates if AS is severe/critical (can precipitate profound hypotension due to fixed outflow obstruction) - use with extreme caution or avoid
Avoid or use with great caution: high-dose beta-blockers/verapamil-diltiazem (severe AS + LBBB risk of complete block) - if used, low dose and only if hemodynamically stable

Medications (individualize with cardiology, adjust for severe AS):

Aspirin 325 mg stat, then 75-150 mg OD
P2Y12 inhibitor (ticagrelor 180 mg loading/90 mg BD or clopidogrel 300-600 mg loading/75 mg OD) - choice depends on planned primary PCI vs conservative route, bleeding risk, and whether urgent AVR may follow
Anticoagulation: unfractionated heparin or LMWH per STEMI protocol/local PCI protocol
Statin: high-intensity (atorvastatin 80 mg OD)
Beta-blocker: hold/defer given severe AS + new LBBB (risk of worsening heart block); reassess after echo/EP input
ACE-inhibitor: hold acutely if hypotensive/severe AS with low output; consider low-dose once stable
Nitrates: avoid/use cautiously (severe AS risk of hypotension/syncope)
Analgesia: morphine/fentanyl for pain if needed, cautiously (hypotension risk)
Antiemetic as needed
Stool softener

Immediate priority: Cardiology consult for emergent coronary angiography +/- primary PCI (door-to-balloon target), with heart-team discussion on concurrent severe AS (balancing MI management against outflow obstruction risk during PCI/hemodynamic instability). Cardiothoracic/structural heart team involvement for AS (TAVR vs SAVR) once acute MI stabilized.

Temporary pacing: Have transcutaneous pacer pads placed at bedside; consider prophylactic temporary transvenous pacemaker if any PR prolongation, higher-degree block, or hemodynamic compromise, given new LBBB in setting of acute MI carries meaningful risk of progression to complete heart block.

3. Further Investigations

Serial troponin (0, 3, 6 hr) and serial ECGs
CBC, renal function tests, electrolytes (K+, Mg2+ - arrhythmia risk), random blood sugar/HbA1c, lipid profile
Coagulation profile (PT/INR, aPTT) before anticoagulation/PCI
Chest X-ray
Coronary angiography (gold standard - confirms LAD lesion, assesses other vessels, guides revascularization)
Repeat/detailed 2D echo with Doppler: LV function/EF, aortic valve area, mean/peak gradients, aortic valve calcium score - to grade AS severity and plan intervention
CT aortic angiogram if any suspicion of aortic dissection (given syncope + chest pain in an elderly patient)
Holter monitoring/telemetry review for transient AV block or ventricular arrhythmia explaining the syncope
BNP/NT-proBNP for heart failure assessment
Thyroid function (as baseline before amiodarone/other cardiac drugs if needed)
If TAVR being considered: CT aortic annulus sizing, peripheral vascular access assessment, carotid Doppler, frailty assessment

4. Complications to Anticipate

From STEMI with new LBBB:

Progression to complete/high-grade AV block (LBBB + acute MI is a recognized precursor)
Cardiogenic shock (higher risk given co-existing severe AS - "double jeopardy" of pump failure + fixed outflow obstruction)
Ventricular arrhythmias (VT/VF), sudden cardiac death
Acute heart failure/pulmonary edema
Mechanical complications: papillary muscle rupture (acute MR), ventricular septal rupture, free wall rupture/tamponade
Left ventricular aneurysm, mural thrombus
Pericarditis (early) or Dressler syndrome (late)
Recurrent/extension of infarction

From severe AS in this setting:

Sudden cardiac death (mean survival without treatment ~2-3 years once syncope has occurred)
Hemodynamic collapse with vasodilators/nitrates/hypovolemia
Worsening syncope or recurrent syncope
Complicated PCI hemodynamics (fixed cardiac output cannot compensate for hypotension from contrast, arrhythmia, or ischemia during catheterization)

5. Adverse Effects to Monitor (from treatment)

Aspirin/P2Y12 inhibitors/heparin: bleeding (GI, intracranial, access-site hematoma), thrombocytopenia (with heparin - watch for HIT)
Statins: myalgia, transaminitis (baseline and periodic LFTs)
Nitrates (if used at all): profound hypotension/syncope - especially dangerous with severe AS, avoid unless absolutely necessary
Beta-blockers (if introduced later): bradycardia, hypotension, worsening AV block
Contrast (for angiography/CT): contrast-induced nephropathy - monitor renal function pre/post, hydrate appropriately
Opioid analgesics: respiratory depression, hypotension, nausea

6. Daily Monitoring Parameters

Continuous cardiac rhythm monitoring (watch specifically for progression of conduction block)
Vitals: HR, BP, RR, SpO2, temperature - trend for shock or arrhythmia
Daily 12-lead ECG (watch for evolving Q waves, resolution of ST elevation, new conduction abnormalities)
Daily troponin until peak/downtrend confirmed, then as clinically indicated
Daily electrolytes (K+, Mg2+) - keep K+ 4.0-5.0 mmol/L to reduce arrhythmia risk
Renal function daily (especially post-contrast)
Strict input/output and daily weight - watch for fluid overload/heart failure
Daily clinical exam: heart sounds/murmur intensity, signs of heart failure (crepitations, JVP, edema), signs of shock (cold peripheries, oliguria, altered sensorium)
Watch for recurrent chest pain, dyspnea, presyncope/syncope, palpitations
Bleeding surveillance (access site, gums, stools, urine) if on dual antiplatelet + anticoagulant
Daily review of need for temporary pacing/escalation to permanent pacemaker

Key teaching point for your case discussion

The critical management tension here is that this patient needs urgent revascularization for STEMI, but severe AS restricts the safe use of standard STEMI adjuncts (nitrates, aggressive beta-blockade, vasodilators) because of fixed cardiac output. He also needs prompt evaluation for AV block given new LBBB in the setting of MI. This is a case for early multidisciplinary heart-team discussion (interventional cardiology + structural/valve team + possibly EP) rather than a single-pathway protocol.

I could not run a live literature check on this final pass (quick-answer mode), but from earlier searches, recent systematic reviews (2023-2025, e.g. PMID 40831305, 36328337, 36198484) discuss early aortic valve replacement timing in severe AS - relevant background for planning definitive valve management once his MI is stabilized. Worth a fresh look with your cardiology team given this is an evolving area.

Working Diagnosis

70-year-old male with anterior wall STEMI (ST elevation V2-V6) with new-onset complete LBBB, raised troponin, echo confirming RWMA in LAD territory, superimposed on severe calcific/degenerative aortic stenosis presenting with syncope, angina, and dyspnea (the classic triad of severe AS, now precipitated/complicated by acute MI). This is a high-risk combination - new LBBB in the setting of STEMI criteria, plus severe AS, means this patient needs urgent cardiology involvement and ICU/CCU-level care.

1. Differential Diagnosis

For the syncope + chest pain + dyspnea presentation:

Acute anterior STEMI with new complete LBBB (most likely, supported by ECG + troponin + echo RWMA)
Syncope secondary to severe aortic stenosis (critical outflow obstruction, exertional/effort syncope)
Paroxysmal complete heart block/high-grade AV block (LBBB can herald this, especially with acute MI)
Ventricular arrhythmia (VT) causing transient syncope, in setting of ischemia and LV dysfunction
Type 2 MI from demand ischemia due to severe AS (fixed obstruction, cannot augment coronary flow) rather than primary plaque rupture
Aortic dissection extending into a coronary ostium (need to exclude, especially if "severe aortic wall degeneration" implies aneurysmal/atherosclerotic aorta) - check BP in both arms, CT aortogram if any suspicion
Pulmonary embolism (breathlessness, syncope) - less likely given ST elevation pattern but should be kept in mind if D-dimer/Wells score indicate

2. Admission Order Sheet (ICU/CCU)

Nursing care level: CCU/ICU admission, strict bed rest, continuous cardiac monitoring, propped-up position (30-45°) if breathless.

Vitals/monitoring:

Continuous ECG (cardiac monitor) - watch for progression to complete heart block, VT/VF
SpO2 continuous
Hourly BP, pulse, RR for first 24-48 hours, then 2-4 hourly
Strict intake-output chart
Daily weight
Temperature charting

Oxygen: Supplemental O2 to keep SpO2 >94% (only if hypoxic; avoid routine O2 if saturating well)

IV access: Two wide-bore IV lines

Diet: NBM initially (if planned for urgent PCI) then liquid/cardiac diet, salt-restricted, low-fat

Medications (typical, adjust to local protocol and confirm no contraindications):

Tab Aspirin 325 mg chewed stat, then 75 mg OD
Tab Ticagrelor 180 mg loading, then 90 mg BD (or Clopidogrel 300-600 mg load then 75 mg OD - choice affected by bleeding risk in elderly and if surgery/TAVR anticipated)
Inj. Heparin (UFH) or LMWH per weight-based protocol (anticoagulation dosing needs caution given age and possible upcoming valve intervention)
Tab/Inj Atorvastatin 80 mg OD (high-intensity statin)
IV Nitroglycerin infusion titrated to chest pain/BP - use with caution, may cause severe hypotension in severe AS (preload-dependent, fixed obstruction)
Beta-blockers - caution/relative caution given complete LBBB and risk of progression to complete heart block; individualize
Analgesia: Inj Morphine 2-4 mg IV for pain if needed (monitor for hypotension/respiratory depression)
Avoid ACE-inhibitors/ARBs acutely if hypotensive or severe AS with low output; can consider low dose once stable if LV dysfunction present
Stress ulcer prophylaxis: Inj Pantoprazole 40 mg IV OD
Bowel/DVT prophylaxis as per protocol

Urgent Plan: Emergency cardiology consult for primary PCI (door-to-balloon target <90 min) given STEMI-equivalent picture (new LBBB + ST elevation + raised troponin). Note: severe AS raises procedural risk (hemodynamic instability with sedation/contrast, need for hemodynamic support standby - IABP/vasopressors available). Cardiothoracic/structural heart team involvement for concurrent severe AS (may need combined revascularization + later TAVR/SAVR).

Temporary pacing standby: Given complete LBBB with ACS, keep transcutaneous pacing pads on / temporary pacemaker on standby given risk of progression to complete heart block.

3. Other Investigations Needed

Serial troponin (already raised) - repeat at 3-6h to assess trend
CK-MB, CBC, RFT, LFT, electrolytes (Na, K, Mg - arrhythmia risk), RBS/HbA1c, lipid profile
Coagulation profile (PT/INR, aPTT) before anticoagulation/intervention
Chest X-ray
Coronary angiography (urgent, given STEMI-equivalent ECG) - will define LAD lesion and guide PCI
Repeat/detailed 2D Echo with Doppler - aortic valve gradient, aortic valve area, LVEF, degree of AS severity confirmation, assess for mechanical complications (papillary muscle dysfunction, VSD, free wall issues)
CT aortogram if any concern of aortic dissection/wall degeneration extending beyond valve
BNP/NT-proBNP
ABG if respiratory distress significant
Blood cultures if febrile/infective endocarditis suspected as cause of valve degeneration
12-lead ECG serial tracings to watch conduction

4. Complications to Anticipate

From STEMI + new LBBB:

Progression to complete heart block (LBBB + acute anterior MI is a recognized precursor)
Ventricular arrhythmias - VT/VF, sudden cardiac death
Cardiogenic shock (especially with large anterior infarct + fixed AS afterload - very poor tolerance)
Acute heart failure/pulmonary edema
Mechanical complications: papillary muscle rupture (mitral regurgitation), VSD, LV free wall rupture, LV aneurysm/pseudoaneurysm
Pericarditis (early peri-infarction or later Dressler syndrome)
Mural thrombus/systemic embolization
Recurrent ischemia/reinfarction

From severe AS:

Sudden cardiac death (well-documented risk once symptomatic)
Worsening heart failure
Hemodynamic collapse during any vasodilation, hypovolemia, or arrhythmia (fixed obstruction cannot compensate)
High peri-procedural risk during PCI/anesthesia due to inability to augment cardiac output

Textbook data point worth remembering: once severe AS becomes symptomatic, untreated mean survival is roughly 5 years with angina, 3 years with syncope, and 2 years with heart failure onset - underscoring the urgency of definitive valve intervention (Frameworks for Internal Medicine).

5. Adverse Effects to Watch (from treatment)

Nitrates/morphine: hypotension, especially dangerous in fixed-obstruction severe AS (preload-dependent) - avoid aggressive preload reduction
Beta-blockers: risk of precipitating complete heart block given existing LBBB, bradycardia, hypotension
Antiplatelets/anticoagulants: bleeding (GI, intracranial, access-site if angiography done), especially in elderly
Statins: myopathy, transaminitis (baseline and monitor LFTs)
Contrast (angiography): contrast-induced nephropathy - check baseline renal function, hydrate appropriately
ACEi/ARB if started: hypotension, renal function decline, hyperkalemia

6. Daily Monitoring Checklist

Vitals (HR, BP, RR, SpO2) - continuous initially, then structured intervals
Daily ECG (watch for arrhythmia, block progression, ST changes)
Daily clinical exam: new murmurs, added heart sounds, signs of heart failure (crepitations, raised JVP, edema), signs of embolization
Strict input/output and daily weight (fluid balance critical in both HF and AS)
Serial troponin/CK-MB until peak and trend down
Daily renal function and electrolytes (especially if on diuretics, ACEi, contrast exposure, or anticoagulation)
Daily CBC (bleeding, infection)
Watch for syncope recurrence, chest pain recurrence, new dyspnea
Glycemic monitoring (stress hyperglycemia common post-MI)
Assess for signs of cardiogenic shock (cool extremities, oliguria, altered mentation, hypotension)
Pacing pad/temporary pacemaker function check if placed

Key Clinical Point

The combination of anterior STEMI (or STEMI-equivalent new LBBB) with concurrent severe AS is a high-risk scenario requiring multidisciplinary decision-making: primary PCI is usually pursued for the acute infarct, but the severe AS significantly raises procedural risk (hemodynamic decompensation with sedation, vasodilation, or arrhythmia) and will likely need TAVR or surgical AVR (possibly combined with CABG if multivessel disease is found on angiography) once the patient is stabilized. This case should go to the cath lab/heart team discussion urgently rather than being managed as a straightforward single-pathology MI.

This is a complex real patient scenario - final orders should be individualized by the treating cardiology team based on actual hemodynamics, renal function, bleeding risk, and angiographic findings.

plz provide me answer

Working Diagnosis

70-year-old male with anterior wall STEMI (ST elevation V2-V6) with new-onset complete LBBB, raised troponin, echo confirming RWMA in LAD territory, superimposed on severe calcific/degenerative aortic stenosis, presenting with syncope, chest pain, and dyspnea. This is a high-risk combination requiring urgent cardiology involvement and ICU/CCU-level care.

1. Differential Diagnosis

Acute anterior STEMI with new complete LBBB (most likely - ECG + troponin + echo RWMA all support this)
Syncope secondary to severe aortic stenosis (fixed outflow obstruction, classic AS triad: angina, syncope, dyspnea)
Paroxysmal complete heart block/high-grade AV block (new LBBB + acute MI can herald this, explaining the syncope)
Ventricular arrhythmia (VT) causing transient syncope from ischemia/LV dysfunction
Type 2 MI from demand ischemia due to severe AS rather than primary plaque rupture
Aortic dissection (given "severe aortic wall degeneration" - check BP both arms, consider CT aortogram before anticoagulation if any suspicion)
Pulmonary embolism (less likely given ST elevation pattern, but keep in mind)

2. Admission Order Sheet (ICU/CCU)

Level of care: CCU/ICU, strict bed rest, continuous cardiac monitoring, propped-up position if breathless

Monitoring: Continuous ECG (watch for progression to complete heart block/VT), continuous SpO2, hourly BP/pulse/RR for 24-48h then 2-4 hourly, strict input-output chart, daily weight

Oxygen: Only if SpO2 <94%

IV access: Two wide-bore lines

Diet: NBM if urgent PCI planned, then salt-restricted cardiac diet

Medications (individualize with cardiology - severe AS changes standard STEMI protocol):

Tab Aspirin 325 mg stat, then 75 mg OD
Tab Ticagrelor 180 mg load then 90 mg BD (or Clopidogrel 300-600 mg load then 75 mg OD)
Inj Heparin/LMWH per weight-based protocol
Tab Atorvastatin 80 mg OD
IV Nitroglycerin - use cautiously, can cause severe hypotension in severe AS (preload-dependent, fixed obstruction)
Beta-blockers - relative caution given complete LBBB (risk of progression to complete heart block); individualize
Inj Morphine 2-4 mg IV PRN for pain (watch for hypotension)
Avoid ACEi/ARB acutely if hypotensive
Inj Pantoprazole 40 mg IV OD (stress ulcer prophylaxis)
DVT prophylaxis per protocol

Urgent plan: Emergency cardiology consult for primary PCI (door-to-balloon <90 min) given STEMI-equivalent picture. Keep transcutaneous pacing pads on/temporary pacemaker on standby given new LBBB + risk of complete heart block. Structural heart/cardiothoracic team involvement for the severe AS (likely TAVR/SAVR once stabilized, possibly combined with CABG depending on angiography).

3. Other Investigations

Serial troponin (3-6h) and serial ECGs
CBC, RFT, LFT, electrolytes (K+, Mg2+), RBS/HbA1c, lipid profile
Coagulation profile (PT/INR, aPTT) before anticoagulation/PCI
Chest X-ray
Coronary angiography (urgent)
Detailed 2D echo with Doppler (aortic valve area, gradients, LVEF, rule out mechanical complications)
CT aortogram if dissection suspected
BNP/NT-proBNP
ABG if in respiratory distress
Blood cultures if endocarditis suspected as cause of valve degeneration

4. Complications to Anticipate

From STEMI + new LBBB: progression to complete heart block, VT/VF/sudden death, cardiogenic shock (poorly tolerated with fixed AS afterload), acute heart failure/pulmonary edema, mechanical complications (papillary muscle rupture, VSD, free wall rupture), LV aneurysm/mural thrombus, pericarditis/Dressler syndrome, reinfarction

From severe AS: sudden cardiac death, worsening heart failure, hemodynamic collapse with vasodilation/hypovolemia/arrhythmia, high peri-procedural risk during PCI

Note: once severe AS becomes symptomatic, untreated mean survival is roughly 5 years with angina, 3 years with syncope, 2 years with heart failure - underscoring urgency of definitive valve treatment.

5. Adverse Effects to Watch

Nitrates/morphine: hypotension (dangerous with fixed-obstruction AS)
Beta-blockers: risk of worsening/complete heart block, bradycardia
Antiplatelets/anticoagulants: bleeding (GI, intracranial, access-site)
Statins: myopathy, transaminitis
Contrast: contrast-induced nephropathy
ACEi/ARB: hypotension, renal decline, hyperkalemia

6. Daily Monitoring

Continuous/structured vitals (HR, BP, RR, SpO2)
Daily ECG
Daily clinical exam: new murmurs, heart failure signs, embolization signs
Strict input-output and daily weight
Serial troponin/CK-MB until trend down
Daily renal function and electrolytes
Daily CBC
Watch for recurrent syncope, chest pain, dyspnea
Glycemic monitoring
Watch for cardiogenic shock signs (cool extremities, oliguria, altered mentation)
Pacing pad/temporary pacemaker function check

Key point: This is a multidisciplinary case - primary PCI for the acute infarct, but severe AS significantly raises procedural risk and will likely need TAVR/SAVR once stabilized. Final orders should be individualized by the treating team based on actual hemodynamics and angiographic findings.

This is a shared conversation. Sign in to Orris to start your own chat.